The selected pure lymphocyte cultures will then be co-cultured with lymphocytes and tumor cells in the presence of irradiated feeder lymphocytes (an antibody targeting ε subunits within human CD3) and IL-2 to rapidly expand for 5 to 6 weeks. The gene discussed is IL2; the disease is neoplasm.